The DDL committee is currently taking submissions for conference papers, for the DDL Emerging Scientist Award (deadline June 30, 2023) and the Pat Burnell Young Investigator Award (deadline July 14, 2023).
Submit conference papers through the DDL Conference web site by July 14, 2023. To find complete guidelines for papers, the conference paper template, and the submission form, visit https://ddl-conference.com/ddl2023/submit-conference-paper/
Papers may address “aspects of developing and testing inhaled drug products, with special focus on innovations in formulation strategy, analytical methodology and delivery devices” and the organizers would especially welcome papers on the conference themes, which for DDL 2023 are:
- Lung Health
Preventing, diagnosing and treating lung disease throughout life. Perspectives from patients, healthcare professionals and the pharmaceutical industry. New treatments, innovative diagnostics, immuno-physiological insights into lung disease and patient centred clinical outcomes. - Emerging Therapeutics
New opportunities for aerosol medicine based on transformative pharmaceutical technologies and the development of biologic drugs and advanced therapies. Insights into formulation design and clinical development of new modalities, including nucleic acid and cell therapies. - Digital Technologies
Computing platforms (health informatics), connectivity, software, and sensors with applications in the design and use of medical devices and inhaled medicines. - Novel Formulations and Process Technology
New concepts in formulation science and the fabrication of aerosol medicines. A focus on novel tools, device components, new process technology and manufacturing methods.
